In this session we discussed the sepsis patient pathway and the impact of new technology on improving antibiotic stewardship and patient outcomes. Current practices in the microbiology laboratory, including antimicrobial-susceptibility testing biomarkers and molecular testing, were discussed along with opportunities that exist in the workflow. There is increasing pressure in laboratories to improve antibiotic stewardship use and associated patient outcomes. Our key experts discussed current practices and innovations needed to improve antibiotic use.

Industry Chair: Dr. Jean Patel

ECCMID Appointed Chair: Prof. Edda Tschernko (Medical University of Vienna)

Presentation: Overview of sepsis patient pathway (clinical case)
Presented by: Dr. Ephraim Tsalik (Danaher Diagnostics Platform - USA)

Presentation: Biomarkers in the sepsis pathway (negative predictive value MDW)
Presented by: Elena Sukhacheva (Beckman Coulter EU)

Presentation: Micro Lab/Conventional AST/Molecular/Gaps
Presented by: Dr. Mandy Wooton (UK)

Presentation: Value adds to AB Stewardship – Is the Micro lab important? Can there be an impact to antibiotic use?
Presented by: Dr. Elisabeth Presterl (Austria)

Presentation: Impact of innovation on improving patient outcomes & AB stewardship
Presented by: Dr. Jean B. Patel (Beckman Coulter Microbiology - USA)

Watch now

Antimicrobial resistance and detection: A continued critical issue

Emerging antimicrobial resistance continues to be a critical issue in today’s healthcare environment. Resistance that was once considered unusual is now routine, and the microbiology laboratory has increasingly many ways, including rapid methods, to test for antimicrobial resistance. This symposium will examine the central role of susceptibility testing and the determination of MICs in a variety of laboratory health care settings. Topics examined include new mechanisms of resistance, laboratory testing protocols and standardization across organizations, and the importance of MICs as well as SIR categories in defining antibiotic treatment, particularly with new antibiotics.

Industry Chair: Barbara L. Zimmer, Ph.D. (United States)
Beckman Coulter, Inc. U.S.A.
Welcome and Introduction

Presentation: Field evaluation of the mini-lab, and all-in-one transportable clinical bacteriology laboratory for low resource settings
Presented by: Jean-Baptiste Ronat, Medecins sans Frontieres, (France)

Presentation: Detection of so-called rare carbapenemases in Enterobacterales- a challenge for the microbiology laboratory
Presented by: Axel Hamprecht, Universitätsmedizin Oldenburg, (Germany)

Presentation: Standardization of resistance testing in a country health care network
Presented by: Kelly Ward, Public Health Wales, (UK)

Presentation: Current and emerging technologies for detection of antimicrobial resistance
Presented by: Rafael Canton, Hospital Universitario Ramón y Cajal, (Spain)

Recordings will be available for pre-registered attendees on-demand 26 April – 26 July 2022.